SCHEMBL18370587

SCHEMBL18370587

c1ccc(-c2nc(-c3ccc4ccccc4c3)nc3oc4ccccc4c23)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 5/20 0.40
▸ KMT2A Q03164 5/20 0.40
▸ ALDH1A1 P00352 4/20 0.40
▸ KDM4E B2RXH2 2/20 0.40
▸ SMN1; SMN2 Q16637 2/20 0.40
▸ HSD17B10 Q99714 2/20 0.40
▸ CYP1A2 P05177 2/20 0.40
▸ TP53 P04637 1/20 0.40
▸ MAPT P10636 5/20 0.39
▸ ADORA2A P29274 3/20 0.39
▸ ADORA1 P30542 3/20 0.39
▸ WHR1 P49842 1/20 0.37
▸ ATM Q13315 1/20 0.37
▸ CSF1R P07333 1/20 0.36
▸ PDGFRB P09619 1/20 0.36
▸ KIT P10721 1/20 0.36
▸ FLT3 P36888 1/20 0.36
▸ HDAC6 Q9UBN7 1/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ HTT P42858 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18370576 0.96 MEN1 (0.38) MEN1KMT2AALDH1A1KDM4ESMN1; SMN2
SCHEMBL18370577 0.96 MEN1 (0.38) MEN1KMT2AALDH1A1KDM4ESMN1; SMN2
SCHEMBL18370593 0.93 PLA2G2A (0.38) MEN1KMT2AALDH1A1KDM4ESMN1; SMN2
SCHEMBL18370586 0.93 PLA2G2A (0.38) MEN1KMT2AALDH1A1KDM4ESMN1; SMN2
SCHEMBL18017936 0.89 PLA2G2A (0.40) MEN1KMT2AALDH1A1KDM4ESMN1; SMN2
SCHEMBL19106477 0.89 CYP1A1 (0.40) MEN1KMT2AALDH1A1KDM4ESMN1; SMN2
SCHEMBL18017693 0.89 WHR1 (0.40) MEN1KMT2AALDH1A1KDM4ESMN1; SMN2
SCHEMBL18017923 0.89 MEN1 (0.45) MEN1KMT2AALDH1A1KDM4ESMN1; SMN2
SCHEMBL18017879 0.89 MEN1 (0.45) MEN1KMT2AALDH1A1KDM4ESMN1; SMN2
SCHEMBL18017783 0.89 MEN1 (0.45) MEN1KMT2AALDH1A1KDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170012216-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG SDI CO., LTD. (KR) 2017-01-12 — — US disclosed
US-20170012216-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG SDI CO., LTD. (KR) 2017-01-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170012216-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 MEN1 838/4885KMT2A 2013/4885ALDH1A1 1905/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback